438 related articles for article (PubMed ID: 26388146)
1. Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.
Scherma M; Dessì C; Muntoni AL; Lecca S; Satta V; Luchicchi A; Pistis M; Panlilio LV; Fattore L; Goldberg SR; Fratta W; Fadda P
Neuropsychopharmacology; 2016 Apr; 41(5):1416-26. PubMed ID: 26388146
[TBL] [Abstract][Full Text] [Related]
2. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats.
Malinen H; Hyytiä P
Alcohol Clin Exp Res; 2008 Nov; 32(11):1976-83. PubMed ID: 18782338
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.
Fanarioti E; Mavrikaki M; Panagis G; Mitsacos A; Nomikos GG; Giompres P
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522428
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model.
Lefever TW; Marusich JA; Antonazzo KR; Wiley JL
Pharmacol Biochem Behav; 2014 Mar; 118():30-5. PubMed ID: 24412835
[TBL] [Abstract][Full Text] [Related]
5. The hypocretin/orexin receptor-1 as a novel target to modulate cannabinoid reward.
Flores Á; Maldonado R; Berrendero F
Biol Psychiatry; 2014 Mar; 75(6):499-507. PubMed ID: 23896204
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid.
De Luca MA; Bimpisidis Z; Melis M; Marti M; Caboni P; Valentini V; Margiani G; Pintori N; Polis I; Marsicano G; Parsons LH; Di Chiara G
Neuropharmacology; 2015 Dec; 99():705-14. PubMed ID: 26327678
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Rat Accumbens Dopamine, Endocannabinoids and GABA Content During WIN55,212-2 Treatment: The Role of Ghrelin.
Charalambous C; Lapka M; Havlickova T; Syslova K; Sustkova-Fiserova M
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379212
[TBL] [Abstract][Full Text] [Related]
8. Delta-9-tetrahydrocannabinol potentiates fear memory salience through functional modulation of mesolimbic dopaminergic activity states.
Fitoussi A; Zunder J; Tan H; Laviolette SR
Eur J Neurosci; 2018 Jun; 47(11):1385-1400. PubMed ID: 29776015
[TBL] [Abstract][Full Text] [Related]
9. Increased BDNF-TrkB signaling in the nucleus accumbens plays a role in the risk for psychosis after cannabis exposure during adolescence.
Dong C; Tian Z; Zhang K; Chang L; Qu Y; Pu Y; Ren Q; Fujita Y; Ohgi Y; Futamura T; Hashimoto K
Pharmacol Biochem Behav; 2019 Feb; 177():61-68. PubMed ID: 30629965
[TBL] [Abstract][Full Text] [Related]
10. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons.
Pistis M; Perra S; Pillolla G; Melis M; Muntoni AL; Gessa GL
Biol Psychiatry; 2004 Jul; 56(2):86-94. PubMed ID: 15231440
[TBL] [Abstract][Full Text] [Related]
11. Mesolimbic dopamine dysregulation as a signature of information processing deficits imposed by prenatal THC exposure.
Sagheddu C; Traccis F; Serra V; Congiu M; Frau R; Cheer JF; Melis M
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110128. PubMed ID: 33031862
[TBL] [Abstract][Full Text] [Related]
12. The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism.
Fois GR; Fattore L; Murineddu G; Salis A; Pintore G; Asproni B; Pinna GA; Diana M
Pharmacol Res; 2016 Nov; 113(Pt A):108-115. PubMed ID: 27521837
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid self-administration increases dopamine release in the nucleus accumbens.
Fadda P; Scherma M; Spano MS; Salis P; Melis V; Fattore L; Fratta W
Neuroreport; 2006 Oct; 17(15):1629-32. PubMed ID: 17001282
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens.
Sperlágh B; Windisch K; Andó RD; Sylvester Vizi E
Neurochem Int; 2009 Jun; 54(7):452-7. PubMed ID: 19428788
[TBL] [Abstract][Full Text] [Related]
15. Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain.
Polissidis A; Chouliara O; Galanopoulos A; Rentesi G; Dosi M; Hyphantis T; Marselos M; Papadopoulou-Daifoti Z; Nomikos GG; Spyraki C; Tzavara ET; Antoniou K
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1175-91. PubMed ID: 19941698
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: a brain stimulation reward study.
Gallo A; Bouchard C; Fortier E; Ducrot C; Rompré PP
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1534-45. PubMed ID: 25092427
[TBL] [Abstract][Full Text] [Related]
17. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats.
Ellgren M; Spano SM; Hurd YL
Neuropsychopharmacology; 2007 Mar; 32(3):607-15. PubMed ID: 16823391
[TBL] [Abstract][Full Text] [Related]
18. CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: A Novel Target for Marijuana.
Friend L; Weed J; Sandoval P; Nufer T; Ostlund I; Edwards JG
J Neurosci; 2017 Nov; 37(45):10943-10954. PubMed ID: 29038246
[TBL] [Abstract][Full Text] [Related]
19. Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats.
Verrico CD; Jentsch JD; Roth RH
Synapse; 2003 Jul; 49(1):61-6. PubMed ID: 12710016
[TBL] [Abstract][Full Text] [Related]
20. CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ
Han X; He Y; Bi GH; Zhang HY; Song R; Liu QR; Egan JM; Gardner EL; Li J; Xi ZX
Sci Rep; 2017 Sep; 7(1):12315. PubMed ID: 28951549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
